Log in to save to my catalogue

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_822db6e3defc4196a740ad1cdce3eff7

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

About this item

Full title

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2023-06, Vol.14 (1), p.3304-3304, Article 3304

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by chronic inflammation and progressive fibrosis of the biliary tree. The majority of PSC patients suffer from concomitant inflammatory bowel disease (IBD), which has been suggested to promote disease development and progression. However, the molecular mechani...

Alternative Titles

Full title

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_822db6e3defc4196a740ad1cdce3eff7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_822db6e3defc4196a740ad1cdce3eff7

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-023-38840-8

How to access this item